Take-at-home brain cancer treatment for children will soon be available on NHS
- A new targeted drug therapy for brain tumors in children, dabrafenib with trametinib, approved by NICE, will now be available through the NHS for those aged 1 to 7 with specific genetic mutations.
- This treatment offers a more effective and less harmful option than standard chemotherapy, with studies showing it can halt tumor growth for an average of 24.9 months, compared to 7.2 months with chemotherapy.
- The therapy targets proteins from the mutated gene causing tumor growth, can be administered at home, and is approved for both low-grade and high-grade gliomas with the BRAF V600E mutation.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left2Leaning Right1Center1Last Updated12 days agoBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 25%
R 25%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage